Lesion of medullary catecholaminergic neurons is associated with cardiovascular dysfunction in rotenone‐induced Parkinson's disease rats

No abstract is available for this paper.

• Publication year

  2015

• Venue

  European Journal of Neuroscience

• Publication date

  2015-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/ejn.13012PMID 26153521
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dysautonomias in Parkinson's disease: cardiovascular changes and autonomic modulation in conscious rats after infusion of bilateral 6-OHDA in substantia nigra.

  2015cited by this paper
• Relationship between duration of illness and cardiac autonomic nervous activity in anorexia nervosa

  2015cited by this paper
• Parkinson's disease as a member of Prion-like disorders.

  2015cited by this paper
• Chronic Testosterone Replacement Exerts Cardioprotection against Cardiac Ischemia-Reperfusion Injury by Attenuating Mitochondrial Dysfunction in Testosterone-Deprived Rats

  2015cited by this paper
• Immediate-early gene expression in structures outside the basal ganglia is associated to l-DOPA-induced dyskinesia.

  2014cited by this paper
• Cardiovascular autonomic nervous system evaluation in Parkinson disease and multiple system atrophy.

  2014influential reference
• Dysautonomia in Parkinson disease.

  2014cited by this paper
• Motor and non-motor features of Parkinson's disease that predict persistent drug-induced Parkinsonism.

  2014cited by this paper
• Premotor parkinsonism models.

  2014cited by this paper
• C1 neurons: the body's EMTs.

  2013cited by this paper
• C1 neurons: the body’s EMTs

  2013cited by this paper
• Reinforcing properties of Pramipexole in normal and parkinsonian rats.

  2013cited by this paper
• Entropy-based complexity of the cardiovascular control in Parkinson disease: Comparison between binning and k-nearest-neighbor approaches

  2013cited by this paper
• The prion hypothesis in Parkinson's disease: Braak to the future

  2013cited by this paper
• Autonomic dysfunction in Parkinson disease.

  2013cited by this paper
• Commissural nucleus of the solitary tract regulates the antihypertensive effects elicited by moxonidine.

  2013cited by this paper
• Pure autonomic failure.

  2013cited by this paper
• Parkinson's Disease: “Braak” to the future

  2013cited by this paper
• Nighttime Blood Pressure and White Matter Hyperintensities in Patients With Parkinson Disease

  2013cited by this paper
• Neurotoxin-based models of Parkinson's disease.

  2012cited by this paper
• Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis.

  2012cited by this paper
• Acetyl-L-carnitine and α-lipoic acid affect rotenone-induced damage in nigral dopaminergic neurons of rat brain, implication for Parkinson's disease therapy.

  2012cited by this paper
• Rotenone-induced parkinsonism elicits behavioral impairments and differential expression of parkin, heat shock proteins and caspases in the rat.

  2012cited by this paper
• Treatment of dysautonomia in extrapyramidal disorders

  2011influential reference
• Pathological roles of α-synuclein in neurological disorders.

  2011cited by this paper
• Heart trouble comes early in Parkinson’s disease before blood pressure falls

  2011cited by this paper
• The nonmotor symptoms of Parkinson's disease—An overview

  2010cited by this paper
• Rg1 protects iron‐induced neurotoxicity through antioxidant and iron regulatory proteins in 6‐OHDA‐treated MES23.5 cells

  2010cited by this paper
• When does Parkinson disease start?

  2010cited by this paper
• The challenge of non-motor symptoms in Parkinson's disease.

  2010cited by this paper
• Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson's disease

  2010cited by this paper
• Cardiovascular autonomic dysfunction in Parkinson's disease.

  2010influential reference
• Review: Treatment of dysautonomia in extrapyramidal disorders

  2010influential reference
• Lesions outside the CNS in Parkinson's disease

  2009cited by this paper
• Loss of nocturnal blood pressure fall in various extrapyramidal syndromes

  2009cited by this paper
• A highly reproducible rotenone model of Parkinson's disease.

  2009cited by this paper
• Cardiac denervation and dysautonomia in Parkinson's disease: a review of screening techniques.

  2008cited by this paper
• Differential behavioral effects of partial bilateral lesions of ventral tegmental area or substantia nigra pars compacta in rats.

  2008cited by this paper
• Early Abnormalities of Vascular and Cardiac Autonomic Control in Parkinson’s Disease Without Orthostatic Hypotension

  2007cited by this paper
• Peripheral iron dextran induced degeneration of dopaminergic neurons in rat substantia nigra.

  2007cited by this paper
• Non-motor dysfunction in Parkinson's disease.

  2007cited by this paper
• Parkinson’s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons

  2007cited by this paper
• Non-motor parkinsonism.

  2007cited by this paper
• Attenuation of homeostatic responses to hypotension and glucoprivation after destruction of catecholaminergic rostral ventrolateral medulla neurons.

  2006cited by this paper
• Housing, husbandry and handling of rodents for behavioral experiments

  2006cited by this paper
• Profound Cardiac Sympathetic Denervation Occurs in Parkinson Disease

  2005cited by this paper
• Stages in the development of Parkinson’s disease-related pathology

  2004influential reference
• Rostral Ventrolateral Medulla C1 Neurons and Cardiovascular Regulation

  2003cited by this paper
• Staging of brain pathology related to sporadic Parkinson's disease.

  2003cited by this paper
• Association Between Supine Hypertension and Orthostatic Hypotension in Autonomic Failure

  2003cited by this paper
• Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease

  2003cited by this paper
• Cardiovascular regulation after destruction of the C1 cell group of the rostral ventrolateral medulla in rats.

  2003cited by this paper
• Circadian heart rate variability in Parkinson's disease

  2002cited by this paper
• Four Faces of Baroreflex Failure: Hypertensive Crisis, Volatile Hypertension, Orthostatic Tachycardia, and Malignant Vagotonia

  2002influential reference
• Cardiac baroreflex control in humans during and immediately after brief exposure to simulated high altitude

  2002cited by this paper
• Nonmotor fluctuations in Parkinson’s disease: Frequent and disabling

  2002cited by this paper
• Differential expression of catecholamine biosynthetic enzymes in the rat ventrolateral medulla

  2001cited by this paper
• Orthostatic Hypotension in Patients with Parkinson’s Disease

  2001cited by this paper
• Motoric behavior in aged rats treated with GM1.

  2001cited by this paper
• Role of the medulla oblongata in hypertension.

  2001cited by this paper
• Regulation of sympathetic tone and arterial pressure by rostral ventrolateral medulla after depletion of C1 cells in rat

  2000cited by this paper
• Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG.

  2000cited by this paper
• Involvement of the ventrolateral medulla in parkinsonism with autonomic failure

  2000cited by this paper
• Identification of C1 presympathetic neurons in rat rostral ventrolateral medulla by juxtacellular labeling in vivo

  1997cited by this paper
• Prevalence of orthostatic hypotension in Parkinson’s disease

  1997cited by this paper
• Neuropathology of autonomic nervous system in Parkinson's disease.

  1997cited by this paper
• Decrease of medullary catecholaminergic neurons in multiple system atrophy and Parkinson's disease and their preservation in amyotrophic lateral sclerosis.

  1995cited by this paper
• Pressor and endocrine responses to lesions of canine rostral ventrolateral medulla.

  1994cited by this paper
• [Pure autonomic failure].

  1993cited by this paper
• Loss of C1 and C3 epinephrine‐synthesizing neurons in the medulla oblongata in parkinson's disease

  1993influential reference
• Central mechanisms regulating blood pressure: circuits and transmitters.

  1992cited by this paper
• Medullary catecholaminergic neurons in the normal human brain and in Parkinson's disease

  1991influential reference
• Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease

  1990cited by this paper
• Catecholaminergic systems in the medulla oblongata in parkinsonian syndromes

  1990cited by this paper
• Reticulospinal vasomotor neurons of the rat rostral ventrolateral medulla: relationship to sympathetic nerve activity and the C1 adrenergic cell group

  1988cited by this paper
• Plasma epinephrine concentration in healthy men: correlation with systolic pressure and rate-pressure product.

  1985cited by this paper
• The rat brain in stereotaxic coordinates: Authors: George Paxinos & Charles Watson Academic Press Australia, 1982 Softback, 154 pages (including 71 plates), 35.00 Aust $

  1983cited by this paper
• Arterial pressure and hormone relationships in phaeochromocytoma.

  1983cited by this paper
• Role of the medulla oblongata in regulating the rhythmogenic function of the smooth musculature

  1982cited by this paper
• Letter: The dean's dilemma.

  1974cited by this paper
• Orthostatic hypotension in Parkinson's disease.

  1972cited by this paper
• Original Papers

  1924cited by this paper
• ON THE OCCURRENCE OF ABNORMAL DEPOSITS OF IRON IN THE BRAIN IN PARKINSONISM WITH SPECIAL REFERENCE TO ITS LOCALISATION

  year unknowncited by this paper

• Intranasally Delivered Mesenchymal Stem Cells Reverses Prodromal Non-Motor Deficits and Nigral Loss in a Parkinson’s Disease Mouse Model

  2026cites this paper
• Untangling the Heart-Brain Connection in Parkinson's Disease: Emerging Mechanisms and Models.

  2025cites this paper
• Novel approaches to improve systemic bioavailability of curcumin using probiotics for rotenone-induced Parkinson's disease in rodents.

  2025cites this paper
• Leveraging animal models to understand non-motor symptoms of Parkinson's disease.

  2025cites this paper
• Investigating the Interplay between Cardiovascular and Neurodegenerative Disease

  2024cites this paper
• Proteomic analysis of human iPSC-derived sympathetic neurons identifies proteostasis collapse as a molecular signature following subtoxic rotenone exposure.

  2024cites this paper
• Astrocyte-derived apolipoprotein D is required for neuronal survival in Parkinson’s disease

  2024cites this paper
• Therapeutic Approaches to Non-Motor Symptoms of Parkinson's Disease: A Current Update on Preclinical Evidence

  2022cites this paper
• Ghrelin Bridges DMV Neuropathology and GI Dysfunction in the Early Stages of Parkinson's Disease

  2022cites this paper
• Baroreflex dysfunction in Parkinson's disease: Integration of central and peripheral mechanisms.

  2021cites this paper
• Hydrogen-saturated saline mediated neuroprotection through autophagy via PI3K/AKT/mTOR pathway in early and medium stages of rotenone-induced Parkinson's disease rats.

  2021cites this paper
• Atremorine in Parkinson's disease: From dopaminergic neuroprotection to pharmacogenomics

  2021cites this paper
• Deficient immunoproteasome assembly drives gain of α-synuclein pathology in Parkinson's disease

  2021cites this paper
• Early low-dose ghrelin intervention via miniosmotic pumps could protect against the progressive dopaminergic neuron loss in Parkinson's disease mice.

  2021cites this paper
• Sirt1/FoxO1-Associated MAO-A Upregulation Promotes Depressive-Like Behavior in Transgenic Mice Expressing Human A53T α-Synuclein.

  2020cites this paper
• The Rotenone Models Reproducing Central and Peripheral Features of Parkinson’s Disease

  2020cites this paper
• Iron‐induced oxidative stress contributes to &agr;‐synuclein phosphorylation and up‐regulation via polo‐like kinase 2 and casein kinase 2

  2019cites this paper
• Autonomic dysfunction in Parkinson disease and animal models

  2019cites this paper
• Glutamate and GABA neurotransmission are increased in paraventricular nucleus of hypothalamus in rats induced to 6‐OHDA parkinsonism: Involvement of nNOS

  2019cites this paper
• The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.

  2018cites this paper
• Glut9-mediated Urate Uptake Is Responsible for Its Protective Effects on Dopaminergic Neurons in Parkinson’s Disease Models

  2018cites this paper
• Investigation of Behavioral Dysfunctions Induced by Monoamine Depletions in a Mouse Model of Parkinson's Disease

  2018cites this paper
• Tyrosine hydroxylase as a sentinel for central and peripheral tissue responses in Parkinson's progression: Evidence from clinical studies and neurotoxin models.

  2018cites this paper
• International Journal of Bioassays

  2017cites this paper
• Parkinson’s Disease: From Pathogenesis to Pharmacogenomics

  2017cites this paper
• Acute action of rotenone on excitability of catecholaminergic neurons in rostral ventrolateral medulla.

  2017influential citation
• E-PodoFavalin-15999 (Atremorine ® )-Induced Neurotransmitter and Hormonal Response in Parkinson’s Disease

  2016cites this paper